These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy. Kwon O; Kang SJ; Kang SH; Lee PH; Yun SC; Ahn JM; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Park SW; Park SJ Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28679524 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point Kang MK; Kim CJ; Choo EH; Han EJ; Hwang BH; Kim JJ; Kim SH; O JH; Chang K Int J Cardiovasc Imaging; 2019 Sep; 35(9):1745-1753. PubMed ID: 31312997 [TBL] [Abstract][Full Text] [Related]
9. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging. Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770 [TBL] [Abstract][Full Text] [Related]
10. Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial. Alfaddagh A; Elajami TK; Ashfaque H; Saleh M; Bistrian BR; Welty FK J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246960 [TBL] [Abstract][Full Text] [Related]
11. Assessment of artery calcification in atherosclerosis with dynamic 18F-FDG-PET/CT imaging in elderly subjects. Al-Enezi MS; Abdo RA; Mokeddem MY; Slimani FAA; Khalil A; Fulop T; Turcotte E; Bentourkia M Int J Cardiovasc Imaging; 2019 May; 35(5):947-954. PubMed ID: 30712152 [TBL] [Abstract][Full Text] [Related]
12. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. Duivenvoorden R; Mani V; Woodward M; Kallend D; Suchankova G; Fuster V; Rudd JHF; Tawakol A; Farkouh ME; Fayad ZA JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322 [TBL] [Abstract][Full Text] [Related]
13. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664 [TBL] [Abstract][Full Text] [Related]
14. Effect of Liraglutide on Arterial Inflammation Assessed as [ Ripa RS; Zobel EH; von Scholten BJ; Jensen JK; Binderup T; Diaz LJ; Curovic VR; Hansen TW; Rossing P; Kjaer A Circ Cardiovasc Imaging; 2021 Jul; 14(7):e012174. PubMed ID: 34187185 [TBL] [Abstract][Full Text] [Related]
15. Peri-Coronary Adipose Tissue Density Is Associated With Kwiecinski J; Dey D; Cadet S; Lee SE; Otaki Y; Huynh PT; Doris MK; Eisenberg E; Yun M; Jansen MA; Williams MC; Tamarappoo BK; Friedman JD; Dweck MR; Newby DE; Chang HJ; Slomka PJ; Berman DS JACC Cardiovasc Imaging; 2019 Oct; 12(10):2000-2010. PubMed ID: 30772226 [TBL] [Abstract][Full Text] [Related]
16. Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease. Hoogeveen RM; Verweij SL; Kaiser Y; Kroon J; Verberne HJ; Vogt L; Moens SJB; Stroes ESG Sci Rep; 2021 Feb; 11(1):4126. PubMed ID: 33602971 [TBL] [Abstract][Full Text] [Related]
17. Individual coronary plaque changes on serial CT angiography: Within-patient heterogeneity, natural history, and statin effects in HIV. Foldyna B; Lo J; Mayrhofer T; Grinspoon SK; Hoffmann U; Lu MT J Cardiovasc Comput Tomogr; 2020; 14(2):144-148. PubMed ID: 31451438 [TBL] [Abstract][Full Text] [Related]
18. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Lo J; Lu MT; Ihenachor EJ; Wei J; Looby SE; Fitch KV; Oh J; Zimmerman CO; Hwang J; Abbara S; Plutzky J; Robbins G; Tawakol A; Hoffmann U; Grinspoon SK Lancet HIV; 2015 Feb; 2(2):e52-63. PubMed ID: 26424461 [TBL] [Abstract][Full Text] [Related]